miRNAs in atherosclerotic plaque initiation, progression, and rupture
Name
Edelman_miRNAs in.pdf
Size
1.45 MB
Format
Adobe PDF
Checksum (MD5)
f4925be49cc0d76bd0718db17f13ecf3
Author(s)
Andreou, Ioannis
Sun, Xinghui
Stone, Peter H.
Edelman, Elazer R.
Feinberg, Mark W.
Date Issued
May 2015
Journal
Trends in Molecular Medicine
Publisher
Cell Press/Elsevier
Citation
Andreou, Ioannis, Xinghui Sun, Peter H. Stone, Elazer R. Edelman, and Mark W. Feinberg. “miRNAs in Atherosclerotic Plaque Initiation, Progression, and Rupture.” Trends in Molecular Medicine 21, no. 5 (May 2015): 307–318.
Version
Author's final manuscript
Abstract
Atherosclerosis is a chronic immune-inflammatory disorder that integrates multiple cell types and a diverse set of inflammatory mediators. miRNAs are emerging as important post-transcriptional regulators of gene expression in most, if not all, vertebrate cells, and constitute central players in many physiological and pathological processes. Rapidly accumulating experimental studies reveal their key role in cellular and molecular processes related to the development of atherosclerosis. We review current evidence for the involvement of miRNAs in early atherosclerotic lesion formation and in plaque rupture and erosion. We conclude with a perspective on the clinical relevance, therapeutic opportunities, and future challenges of miRNA biology in understanding the pathogenesis of this complex disease.
MIT Department
Institute for Medical Engineering and Science
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.molmed.2015.02.003
